M7583 Relative Bioavailability of Tablet Compared to Powder-in-capsule

NCT03297983 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: M7583

Sponsor

Merck KGaA, Darmstadt, Germany